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Abstract
Background: Cancer stem cells exhibit close resemblance to normal stem cells in phenotype as well as function. Hence,
studying normal stem cell behavior is important in understanding cancer pathogenesis. It has recently been shown that
human breast stem cells can be enriched in suspension cultures as mammospheres. However, little is known about the
behavior of these cells in long-term cultures. Since extensive self-renewal potential is the hallmark of stem cells, we
undertook a detailed phenotypic and functional characterization of human mammospheres over long-term passages.
Methodology: Single cell suspensions derived from human breast ‘organoids’ were seeded in ultra low attachment plates in
serum free media. Resulting primary mammospheres after a week (termed T1 mammospheres) were subjected to passaging
every 7th day leading to the generation of T2, T3, and T4 mammospheres.
Principal Findings: We show that primary mammospheres contain a distinct side-population (SP) that displays a CD24
low/
CD44
low phenotype, but fails to generate mammospheres. Instead, the mammosphere-initiating potential rests within the
CD44
high/CD24
low cells, in keeping with the phenotype of breast cancer-initiating cells. In serial sphere formation assays we
find that even though primary (T1) mammospheres show telomerase activity and fourth passage T4 spheres contain label-
retaining cells, they fail to initiate new mammospheres beyond T5. With increasing passages, mammospheres showed an
increase in smaller sized spheres, reduction in proliferation potential and sphere forming efficiency, and increased
differentiation towards the myoepithelial lineage. Significantly, staining for senescence-associated b-galactosidase activity
revealed a dramatic increase in the number of senescent cells with passage, which might in part explain the inability to
continuously generate mammospheres in culture.
Conclusions: Thus, the self-renewal potential of human breast stem cells is exhausted within five in vitro passages of
mammospheres, suggesting the need for further improvisation in culture conditions for their long-term maintenance.
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Introduction
Stem cells are found in many adult tissues and play a critical
role in tissue homeostasis throughout life. Although few in an
organism, these cells can repopulate an entire tissue when
required, such as during injury or disease, by virtue of their long
term self-renewal potential and the ability to generate heteroge-
neous progeny [1]. However, the long life span coupled with
extensive proliferation potential of several adult stem cells also
makes them attractive candidates for accumulating multiple
mutations. The recent identification of a rare population of
cancer stem cells within several cancers [2–6], with both
phenotypic and functional resemblances to normal stem cells,
further supports the notion that normal stem cells may be the
cellular origin of cancer. Therefore understanding stem cell
behavior is fundamental not only for our understanding of normal
development but also carcinogenesis.
Both normal and cancer stem cells have been identified in the
mammary gland [7–10]. The adult mammary gland, organized as
a ‘mammary tree’, has a lobulo-alveolar structure, composed of
luminal cells that lie along the interior surfaces of ducts and alveoli,
and myoepithelial cells underlying the basement membrane of the
ductal-alveolar network [11]. Functional evidence for the presence
of mammary epithelial stem cells was first demonstrated in rodents
by transplantation studies that showed generation of functional
mammary tree by transplantation of mammary outgrowths into
cleared fat pads of syngeneic mice [12]. More recently, mammary
stem cells have been identified based on expression of a
combination of cell surface markers such as Sca-1, CD24 and
CD49f. Indeed a single murine mammary stem cell was shown to
generate a complete, functional mammary gland in vivo [13,14],
thereby demonstrating their long term self-renewal potential as
well as their ability to differentiate into all the cell types that form a
normal functional mammary gland.
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gland came from studies of X chromosome inactivation. Adjacent
patches of the epithelium had inactivation of the same X
chromosome, indicating that these cells arose from a single
primitive cell [15], [16]. Further evidence came from the
observation that the same genetic lesion could be detected in an
entire duct or lobule of a histologically normal mammary
epithelium [17]. It was also demonstrated that luminal and
myoepithelial cells from the same region of the breast show similar
patterns of loss of heterozygosity, indicating a common progenitor
[18]. Even though some putative markers such as p21, Musashi 1,
CD49f, Cytokeratin 19 (CK19), Bmi-1 and ESA
+Muc1
2 [10]
have been suggested for human breast stem cells, no definitive
markers have yet been identified, thereby limiting their isolation
and characterization.
The inability to maintain adult stem cells in an undifferentiated
state in vitro has further marred their characterization. Recently,
enrichment of human breast stem/progenitor cells as non-
adherent mammospheres in serum-free media was demonstrated
[19], based on the strategy adopted for neuronal stem cell culture
as neurospheres [20]. Primary mammosphere-derived cells can
initiate secondary mammospheres, as well as differentiate to give
rise to various breast lineages, thereby exhibiting two fundamental
properties of stem cells – self-renewal and multilineage differen-
tiation. Additionally, both murine and human mammospheres
have the potential to generate ductal-alveolar outgrowths in vivo,
further demonstrating the existence of stem cells within these units
[21], [22]. Thus, the mammosphere system offers an in vitro
model to study mammary stem cell biology. Indeed, the
involvement of Notch and Hedgehog signaling pathways in
regulating mammary stem cell self-renewal has been demonstrated
using the mammosphere system [22,23]. However, little is known
about the behavior of breast stem cells within mammospheres in
long-term cultures.
In order to better comprehend the mammosphere system for its
potential use in long-term maintenance of stem cells in culture, we
have undertaken a thorough phenotypic and functional character-
ization of mammospheres. We show that the side population and
sphere forming potential resides within two distinct subpopulations of
CD24/44 dual stained mammospheres. In serial sphere formation
assays, we find variations in size, number, proliferation, and
differentiation status of mammospheres over passages. Importantly,
we fail to detect generation of new mammospheres beyond the fifth
passage despite the presence of live, proliferating and label retaining
cells. Staining for senescence-associated b-galactosidase activity
revealed a dramatic increase in the number of senescent cells with
passage, which might in part explain the inability of these cells to
continuously generate mammospheres in culture.
Materials and Methods
Collection and processing of breast tissue
Normal breast tissue was obtained from Kidwai Memorial
Institute of Oncology (KMIO) Bangalore, as per the Institutional
Review Board, in compliance with the ethical guidelines of KMIO
and the Indian Institute of Science. Patient consent was obtained in
a written form prior to surgery, as per the protocol approved by the
IRB of KMIO. Tissue was collected 6 cm away from or diagonally
opposite to tumor site by pathologists at KMIO from mastectomy
cases. H & E staining on the tissues confirmed their normal state.
Tissues were collected in DMEM (minus phenol red) containing
penicillin, streptomycin, gentamycin and fungizone and dissociated
mechanicallyandenzymaticallyusing 1 mg/mlCollagenase (Sigma
Aldrich) and 100 U/ml Hyaluronidase (Calbiochem) at 37uC for
16–18 hours with rotation. Breast organoids were separated by
differential centrifugation and seeded in 50-mm low attachment
plate in serum free DMEM-F12 media containing 10 ng/ml hEGF,
1 mg/ml hydrocortisone, 10 mg/ml insulin, 20 ng/ml bFGF, 4 ng/
ml heparin (Sigma Aldrich), B27 (Invitrogen) as described earlier
[19] supplemented with antibiotics.
Culture of mammospheres
The organoids were enzymatically dissociated into single cells
after 6–8 hrs in culture and typically 2.5610
5 cells seeded per well
in 6-well ultra low attachment plates (Corning). Mammospheres
formed after 7 days were collected by centrifugation at 1000 rpm.
For serial passaging, total number of mammospheres obtained at
each passage was counted microscopically under a manually
prepared ‘quadrant grid’, enzymatically dissociated into largely
single cells, and seeded again in low attachment plates after live
cell count. Sphere formation efficiency at each passage was
calculated by dividing the total number of spheres formed by the
total number of live cells seeded multiplied by hundred.
Immunocytochemistry and microscopy
Staining of intact spheres was done, both in suspension and by
fixation onto coated slides. Fixation was done with 1:1 220uC
prechilled Methanol: Acetone for 10 mins. at room temperature
(RT). Prior to permeabilsation, a short trypsin treatment was done
to the fixed spheres for 3–5 mins., only for intracellular antigens.
No such treatment was done for cell surface antigen like E-
Cadherin. Permeabilisation was done in conjunction with blocking
in 0.2% Fish Skin Gelatin using 0.5% Triton 6100 for 1 hr. This
was followed by incubation with primary antibody for 2 hrs at RT.
Primary antibodies were used at dilutions as specified by the
manufacturer. Secondary antibody directly conjugated to a
suitable flurophore was added and incubated for 45 min at room
temperature in dark. Propidium Iodide (PI) was added as counter
stain at a concentration of 0.5 ug/ml with the last PBS wash,
incubated for 5 mins. at room temperature before mounting.
DABCO was used as an antifade agent in the mounting media.
Edges were sealed & the slides viewed using Zeiss 510 Meta
confocal laser scanning microscope and analyzed using LSM
Image Browser. For single cell staining, spheres were first
trypsinised, fixed on slides, stained as above and viewed under
fluorescence microscope (Leica). Antibodies against E Cadherin
(BD Biosciences); ESA, Cytokeratins 14 and 18 (Sigma Aldrich);
Cytokeratin 19 (Calbiochem) were used.
Confocal Imaging & Image Analysis
A Zeiss 510 Meta confocal laser scanning microscope was used
to view the immunoflourescence staining. The 488, 543 or 660 nm
laser lines were used for excitation of the fluorophores, while
emissions were collected by specific band pass filters. Since the
spheres are 3 dimensional specimens, optical sectioning was done
along the XZ-plane to get a Z stack of the specimen.
SP analysis
Standardisation of the protocol for SP was done in HeLa cells
and C57/black BL6 mouse bone marrow cells. After trypsinisation
of cells, 5610
5 cells was given a PBS wash and incubated with
1 ml of DMEM-F12 media and incubated at 37uC for 15 min.
This was followed by addition of Hoechst 33342 at a final
concentration of 2.5 mg/ml. To block Hoechst efflux, either
Verapamil was added at a final concentration of 50 mMo r
Cyclosporin A was added at a concentration of 20 mM. The tubes
were incubated in the dark at 37uC and 5% CO2 for 120 mins.
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washes with PBS. For Rhodamine 123 staining, the dye was added
upto a final conc. of 0.5 mg/ml and incubated at 37uC for
45 mins. This was followed by incubation in Rhodamine free
medium for 30 mins. Cells were given a wash with cold PBS after
staining and were analysed on the LSR-II machine (Becton
Dickinson) . Hoechst 33342 was excited with a 355 nm UV laser.
Emissions were collected in the blue and red channels using the
440/40 BP and 675 LP filters respectively. Immediately before
analysis, Propidium Iodide (PI) was added at a final concentration
of 2 mg/ml.
CD44 and CD24 expression analysis on mammosphere
cells
Mammosphere cells were incubated with anti CD24-FITC and
anti CD44-PE antibodies (Becton Dickinson) in dark, on ice, for
45 mins, washed twice with cold PBS, resuspended in complete
media and kept on ice till subsequent analysis on MoFlo (Dako).
50,000 cells from each quadrant were sorted in 1 ml complete
media and seeded in 24 well Ultra low attachment plate (Corning).
Fordual stainingofSPand CDmarkers,staining forSPwas done at
RTfollowed bystainingforCD24 and44 onice as describedabove.
Proliferation assay
BrdU was added immediately after seeding cells to a final
concentration of 10 mM. Cells were incubated with BrdU for a
week at 37uC & 5% CO2 during which they formed spheres.
These spheres were then dissociated into single cells and stained
with Anti-BrdU antibody. Fixation was done using 70% ethanol.
HCl treatment was done to remove the histones. Secondary
antibody used was conjugated with FITC. The other steps of
staining were the same as described earlier. PI was used as
counterstain. Staining for BrdU was done for mammospheres at
every passage. For each staining experiment, a negative control
was included, in which primary antibody had not been added.
Imaging of intact spheres stained for BrdU was done on the
confocal laser scanning microscope & optical sectioning was done
as described above to analyse the staining profile in all the layers of
a mammosphere. Imaging of stained single cells was done in a
regular fluorescence microscope (Leica). In order to quantify the
proliferation status of cells within mammospheres of each passage,
10 random fields were captured during imaging. Total cell count
and total positive cell count was taken over the random fields post
imaging. A grand total of all the fields was obtained by adding up
numbers from the random fields. This was done for 3 independent
tissues at each passage and a graph was plotted subsequently to
represent the proliferation status of mammosphere derived cells
through multiple passages.
Label Retention Assay
BrdU (10 mM) was added to 2.5610
5 cells/ well of a 6-well ultra
low attachment plate. At each passage (one week) a single well was
harvested for BrdU staining, while the other wells were
enzymatically dissociated and subjected to serial mammosphere
assay without further addition of BrdU. Intact spheres from all the
passages were subjected to BrdU staining and viewed by confocal
microscopy.
Senescence Assay for b - Galactosidase
Single cells obtained by enzymatic digestion of the spheres of
each passage were given a wash with ice cold PBS followed by
fixation with 0.2% glutaraldehyde at RT for 5 minutes. Post
fixation, the cells were resuspended in buffer (pH 6.0) containing
1 mg/ml X-Gal and incubated in the dark at room temperature
for 12 to 14 hours. The X-Gal was quenched by washing with ice
cold PBS. The cells were viewed and counted under a regular
phase contrast microscope.
Results
Mammospheres reveal cellular heterogeneity
Normal breast tissue was subjected to mechanical disruption
followed by enzymatic treatment that resulted in the release of
breast ‘organoids’ (Fig. 1Aa). Further enzymatic digestion of the
organoids yielded single cells that were seeded in low-attachment
plates in media devoid of serum (see Materials and Methods).
Floating spheroids, termed mammospheres, were observed within
5–7 days (Fig. 1Ab) as described previously [19]. Cells obtained by
the enzymatic dissociation of mammospheres at each passage were
further seeded under similar culture conditions for serial mammo-
sphere assays. We have termed the enzymatic dissociation of
organoids leading to the generation of primary mammospheres as
‘T1’, such that the subsequent passages of mammospheres were
termed as T2, T3 etc. Accordingly, the spheres obtained after the
first trypsinisation were termed as ‘T1’ spheres and so on. The
time interval between each passaging was one week.
In order to understand the cellular architecture of mammo-
spheres, we utilized confocal laser scanning microscopy to view and
analyze cells in each plane through the entire sphere. Optical
sections taken through propidium iodide (PI) stained spheres
revealed that mammospheres are compact cellular structures
(Fig. 1Ba). The mammospheres obtained after 7 days ranged in
size from 40–110 mm in diameter, with the majority of spheres
having a diameter of 75 mm. For a sphere of 110 mm diameter, the
number of cells varied between 200 and 250, while a sphere of
40 mm contained ,25 cells. The size of individual cells comprising
the mammospheres varied from 9 to 15 mm (Fig. 1Bb), with ,70%
of the cells having a diameter between 12 and 15 mm. On analyzing
the size of mammospheres through subsequent passages, we found
that the size of the largest and smallest spheres in each passage
remained consistent; however, the relative proportion of smaller
spheres increased in number with passage (data not shown).
Further analysis of the cellular composition of mammospheres
by immunocytochemistry revealed that when compared with the
negative control (Fig. 1Ca), cells within the sphere stained positive
for epithelial markers, (E)-Cadherin and ESA (Fig. 1Cb and c),
while being negative for haematopoeitic and neuronal stem cell
markers, CD34 and nestin (Fig. 1Cd and e). This indicates that the
mammospheres are epithelial in nature and are not derived from
haematopoeitic or neuronal stem cells. Staining for cytokeratin 14
and 18 (CK14 and 18) , which mark the myoepithelial and luminal
cells, respectively, revealed positivity for both within primary
mammospheres, albeit at varying proportions. While 70% cells
were positive for CK18 (Fig. 1Da), 7% cells were positive for
CK14 (Fig. 1Db). Additionally, staining for CK19, which marks
early progenitors and luminal epithelial cells [24] revealed 30% of
cells staining for CK 19 (Fig. 1Dc). Staining of intact spheres
followed by Z-stack analysis by confocal microscopy revealed that
these cytokeratins were uniformly distributed within the spheres
with no particular preference for any cell type within the core or
the periphery of the sphere (Supp Fig. S1A and B). Thus, primary
mammospheres are composed of a heterogeneous population of
cells containing both differentiated and undifferentiated cells.
Mammospheres exhibit telomerase activity
While most somatic cells are devoid of detectable telomerase
activity, some adult stem cells exhibit telomerase activity [25]. In
Long Term Mammosphere Culture
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5329Figure 1. Phenotypic characterization of mammospheres. A: Representative phase contrast photomicrographs of organoids derived from
primary human breast tissue;610 objective (a) and a primary mammosphere formed in suspension after 7 days;610 objective (b). B: Measurement
of mammosphere size; 610 objective (a) and cell size comprising the sphere (b) using LSM Image Browser from the Carl Zeiss website. C:
Immunostaining of intact mammospheres viewed using a Zeiss 510 Meta confocal laser scanning microscope, and optical sectioning done along the
XZ-plane to get a Z stack of the specimen. Photomicrographs represent negative control (minus primary antibody) (a), positive immunostaining for E-
Cadherin (b) and Epithelial Specific Antigen (ESA) (c), but not for CD34 (d). RT-PCR analysis shows lack of nestin transcripts in mammospheres
compared to U251 glioma cell line used as positive control (e). D: Photomicrographs represent immunostaining of single cells derived from primary
Long Term Mammosphere Culture
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carried out multiple assays in primary mammospheres. The
spheres were found to be positive for telomerase expression as
detected by RT-PCR analysis for the catalytic subunit of
telomerase, hTERT (Fig. 1Ea). In addition, TRAP assay further
revealed telomerase activity in primary and secondary mammo-
spheres (Fig. 1Eb and Supp Fig. S1C and 1D). Unlike an earlier
study that failed to detect telomerase activity by TRAP assay in
primary breast tissue [26] we detected telomerase activity in
primary mammospheres, indicating that mammospheres are
enriched in stem cells.
Mammospheres contain label-retaining cells
Adult stem cells have been identified in several systems by label
retention assays wherein the slow dividing property of stem cells
causes them to retain labels such as BrdU or tritiated thymidine,
while the fast proliferating progenitors dilute them out with time
[27]. In order to find if mammospheres contain such label
retaining cells (LRCs), we pulsed mammospheres with BrdU for
seven days and thereafter chased the label for a month with
periodic passaging every 7
th day (Fig. 1F). At the end of first week,
T1 mammospheres showed the presence of 5–10 BrdU positive
cells per sphere (Fig. 1Fa). After one month of chase, 68% of the
T4 spheres retained only 1–2 BrdU positive cells located mostly at
the periphery of the spheres (Fig. 1Fd), while the rest contained
none. Thus, mammospheres contain few label retaining cells at the
end of one month that may represent putative stem cells.
Mammospheres harbor Hoechst and Rhodamine
effluxing cells
Many stem cells are endowed with the ability to efflux certain
lipophilic drugs due to their cell surface expression of ABC family
of membrane transporter proteins [28]. This property has been
widely exploited to identify and isolate stem cells from several
tissues, such as blood, brain, liver, muscle and others using
Hoechst 33342 [29,30]. The dye effluxing cells appear as a low
fluorescing population, termed as the ‘Side Population’ (SP) [31].
In the presence of chemical inhibitors of the membrane
transporters, like verapamil or cyclosporin A, this side population
disappears. Another small molecule which has been reported to be
effluxed by stem cells is Rhodamine123 [32] such that in a FACS
histogram stem cells are marked by the Rhodamine-low (Rho
low)
population. Both SP and Rho
low fraction encompassing stem cells
have been reported for multiple normal tissues [31–34].
When primary mammosphere-derived cells were subjected to
SP analysis we observed a distinct side population comprising
0.5%–1% of the mammosphere cells, which disappeared on
treatment with verapamil or cyclosporin A (Fig. 2A). A previous
report had documented the presence of 30% SP cells within
primary mammospheres [19]. However, in this study instead of a
distinct population, a large fraction of cells, including Hoechst
low
and Hoechst
high cells, disappeared in the presence of verapamil.
We find that this experiment fluctuates with slight variations in
concentration and time of incubation with Hoechst, pH and
temperature. Accordingly, we did our experiments in parallel with
mouse bone marrow samples where we constantly found a pattern
of SP which is well established in the literature (Supp Fig. S2A and
B) [31]. Similar to bone marrow, we find a tight SP population in
the primary mammospheres. Thus, our experiments reveal that
mammospheres contain a small fraction of cells that show the SP
phenotype.
When primary mammosphere derived cells were treated with
Rhodamine123, we observed two distinct populations – Rho
high
and Rho
low (Fig. 2Ba). We asked if the Rho
low population was the
same as ‘SP’. In a simultaneous Rhodamine and Hoechst staining
experiment, when SP cells were gated onto the Rhodamine plot,
the ‘SP’ (Fig. 2Bb) indeed represented a subpopulation within the
Rho
low population (Fig. 2Bc).
Mammosphere forming potential resides within the
CD24
lowCD44
high subpopulation
A major obstacle in breast stem cell biology is the absence of a
specific marker(s) to identify this small population of cells. In some
tissues, such as hematopoietic and neuronal tissues, normal and
cancer stem cells have been shown to share the same cell surface
markers [2,4]. In the case of breast tissue, breast cancer stem cells
have been identified as CD24
lowCD44
high cells [3]. We asked if
this marker phenotype would also hold true for normal breast stem
cells. Flow cytometry analysis of primary mammosphere-derived
cells stained for CD24 and CD44 revealed differentially stained
populations for the two markers (Fig. 2Ca and Supp Fig. S3A). In
order to find out which of these fractions housed cells capable of
initiating mammospheres, we sorted out the same number of cells
from different quadrants and assessed their sphere forming ability
(Fig 2Cb). We observed sphere formation only in the
CD24
lowCD44
high fraction which represented about 12–15% of
the total population, indicating that normal breast stem/
progenitor cells can be identified by a CD24
lowCD44
high
phenotype, in keeping with that for breast cancer stem cells.
In order to understand the correlation between CD24/44
marker profile and SP in mammospheres, we undertook a
simultaneous CD 24/44 and SP staining (Fig. 2Da–d). To our
surprise we observed that the ‘SP’ cells were present within the
CD24
lowCD44
low fraction (Fig. 2Dd) that we previously showed
fails to initiate mammospheres, suggesting that breast SP cells may
lack sphere forming potential. This is in contrast to a previous
report which showed that SP from mammospheres had the
potential to initiate spheres [19]. However, this previous study had
not done a parallel CD24/44 marker staining, and as mentioned
earlier, also failed to show a distinct side-population. Based on our
data we report that in normal primary mammospheres the SP cells
do not fall within the breast cancer stem cell phenotype of
CD24
lowCD44
high.
Mammospheres fail to form beyond the fifth passage
The ability of primary mammospheres/neurospheres to gener-
ate secondary spheres illustrates their self-renewal property
[19,20]. Stem cells within the body, however, need to possess
long term self-renewal potential so as to carry out tissue repair and
sustain homeostasis throughout adult life. Therefore, to assess the
mammospheres showing positivity for CK18 (a) CK14 (b) and CK19 (c). Insets show confocal images of intact spheres stained for the corresponding
antigen. Hoechst 33342 and propidium iodide (PI) were used as nuclear counter stains for single cell and intact spheres, respectively (blue, Hoechst
33342; green, FITC; red, PI; scale bar=20 mm). E: Gel picture shows hTERT expression in primary mammospheres (MS) by RT-PCR using HeLa as a
positive control (a). Bar graph represents quantitative real time RT-PCR for hTERT expression in mammospheres compared to HeLa using primary
human diploid fibroblasts (hF) as negative control (b). F: Mammospheres show few label retaining cells in T4 spheres. (a–d) represent
photomicrographs of mammospheres immunostained for BrdU at each passage. (green, FITC signal; scale bar=20 mm).
doi:10.1371/journal.pone.0005329.g001
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vitro, we carried out serial mammosphere assays. We observed an
increase in sphere forming efficiency from T1 to T3 (from ,0.2%
to ,0.6%), but a decline thereafter (Fig. 3A). Interestingly, we
failed to detect mammosphere formation beyond the fifth passage
in more than 20 independent breast tissues. Trypan blue analysis
revealed cell death at every passage with a ten-fold overall cell loss
from T1 to T4 (Fig. 3B). In order to confirm that the inability of
sphere formation is not due to small number of cells left behind at
T4, we used varying cell densities. We observed similar result
independent of the starting cell numbers varying from 0.1–1
million cells. After the fifth passage, mostly single cells and few
clumps of cells were seen. When left in culture for more than 20–
25 days, mostly single cells with few cells containing large vacuoles
were detected, but no new mammospheres formed even though
trypan blue staining revealed 85% live cells (data not shown).
Thus, lack of mammosphere formation could not be attributed to
the absence of live cells beyond the fifth passage. Furthermore, the
ability of mammospheres to generate acinar structures in matrigel
and cells with multilineage differentiation potential under
differentiating conditions (Supplementary Fig S4) indicated their
stemness to begin with [19]. So, unlike the primary human fetal
central nervous system derived neurospheres that could be
passaged as spheres up to 30 times [35], adult human breast
tissue derived mammospheres could be passaged only five times in
culture. Also, unlike the several-fold expansion of neurospheres,
mammospheres showed marginal increase in sphere forming
efficiency.
Alterations in proliferation with serial passaging
Since mammosphere formation involves proliferation, lack of
proliferation could also result in the observed lack of mammo-
sphere formation during serial passaging. Accordingly, we tested
for the presence of proliferating cells through different passages
using BrdU incorporation assay. Mammospheres from T1, T2, T3
and T4 passages contained on an average 3%, 6%, 13% and 10%
proliferating cells, based on results obtained from five independent
tissues (Fig. 4A). Interestingly, the trend of proliferation of
mammosphere derived cells from T1 to T4 corroborated exactly
with the trend seen for sphere forming efficiency at each passage
(Fig. 4B). However, despite the presence of live, proliferating, and
label retaining cells at T4, no new spheres were initiated beyond
the 5th passage.
Increase in the number of differentiated cells with serial
passaging
Since only stem/progenitor cells, but not the differentiated cells,
have the potential to generate mammospheres, an increase in the
number of differentiated cells with serial passaging may also
account for reduced mammosphere formation. To determine this,
we analyzed the differentiation status based on expression of
CK14 and 18 over different passages. The CK14 positive
myoepithelial cell population increased from 7–30% from T1–
T4, while the CK18 positive luminal epithelial cells population
remained uniform, between 60–70%, across passages (Fig. 4C and
D). Thus, the increase in the CK14 positive population, suggesting
a preferential differentiation towards the myoepithelial lineage in
long-term culture of mammospheres, may contribute in part to the
reduction of sphere formation with passage, but may not account
for the total lack of sphere formation after the fifth passage.
Figure 3. Analysis of serial mammosphere formation. A: Bar
graph represents the sphere forming efficiency (SFE) calculated by
counting the number of mammospheres formed in a given well using a
manually prepared grid and dividing this by the total number of cells
seeded in the well, represented as percentage (n=7). B: Bar graph
represents cell death across different passages calculated by taking the
difference in live cell count (Trypan blue exclusion) between each
passage (n=5). Statistical analysis for A and B was done using One Way
ANOVA; ** signifies p,0.005 . Error bars represent standard deviation.
doi:10.1371/journal.pone.0005329.g003
Figure 2. Analysis of efflux property and surface marker profile of primary mammospheres. A: Side Population (SP) analysis of primary
mammosphere-derived cells from two individual samples (a and b) reveal distinct SP. The top panels represent cells treated with Hoechst 33342 only
(H), while the bottom panels represent cells treated with ABC transporter inhibitors verapamil (H+V) or cyclosporine (H+C). B: FACS profile of primary
mammosphere-derived cells treated with Rhodamine 123 (a). In a simultaneous treatment of cells with Hoechst and Rhodamine, the SP (b) gated
onto the Rhodamine profile (c) revealed that SP falls in the Rho
low region. C: FACS profile of mammosphere-derived cells immunostained with anti
CD24-FITC and anti CD44-PE antibodies (bottom) compared to unstained cells (top) (a). When 50,000 cells from different fractions were sorted and
seeded in a 24-well ultra low attachment plate to assess sphere-forming ability (b), only the CD24
lowCD44
high fraction (4A and 4B) generated
mammospheres. D: Mammosphere-derived cells, when simultaneously stained for CD24/44 and SP, revealed that SP falls in the CD24
lowCD44
low
fraction. Dot plots represent unstained (a), CD24/44 profile (b), SP profile (c) and SP cells gated on to the CD24/44 profile (d).
doi:10.1371/journal.pone.0005329.g002
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passage
Primary cells in culture are known to undergo senescence after a
few passages, which varies from one cell type to the other [36]. In
serum containing attachment cultures, primary breast epithelial
cells can undergo .20 population doublings before they show
signs of senescence [37]. In serum deprived attachment conditions,
these cells undergo 15–20 population doublings before hitting
senescence [38]. However in serum deprived, suspension cultures,
this phenomenon needs to be explored. This led us to test if the
cells beyond T5 had attained senescence. Cells at every passage
were assayed for senescence associated b Galactosidase (SA- b Gal)
activity, a marker of senescent cells [39]. We observed a marked
increase in SA-b Gal activity after T2, such that in T4
mammospheres an average of 60% cells were senescent (Fig 5A
and B). The cells present in culture beyond the fifth passage, with
regular media change every five days, consistently stained positive
for SA-b Galactosidase activity. Thus, increase in senescent cells
may contribute largely to the inability to generate mammospheres
at later passages.
Discussion
The ability to grow in serum-free and anchorage-independent
conditions as multicellular spheroids has been exploited for the
isolation of stem/progenitor cells in several systems [19,20,40,41].
Within a given tissue, however, stem cells are embedded in niches
which provide them with appropriate cues to divide, differentiate,
or remain quiescent. Therefore, in suspension cultures in vitro, in
the absence of its natural microenvironment, whether human
mammary stem cell properties can be sustained for prolonged
periods was not known. We have reported here a detailed
characterization of human breast tissue-derived mammospheres
over long term culture and demonstrated that mammospheres fail
to initiate new spheres beyond the fifth passage.
Heterogeneity within mammospheres
Morphological characterization of mammospheres indicated
that the spheres were of variable sizes ranging between 40 to
110 mm with an increase in smaller size spheres with passage. The
difference in the size of the spheres may reflect the cell type of
Figure 4. Proliferation and differentiation status of mammosphere derived cells. A: Bar graph represents BrdU incorporation based
proliferation analysis at every passage. Ratio of BrdU positive cell and total cell count was taken over random fields and represented as percentage. B:
Graph represents comparison of proliferation potential and sphere forming efficiency from T1 to T4 (n=5). C and D: Graphs represent differentiation
status of cells within mammospheres from T1 to T4 passage as assessed by immunostaining for CK14 and CK18. (n=4). Statistical analysis of this data
was done using One Way ANOVA; * signifies p,0.05, ** signifies p,0.005. Error bars represent standard deviation.
doi:10.1371/journal.pone.0005329.g004
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progenitors, and larger spheres originating from stem cells. Also,
the presence of cells of variable sizes within the mammospheres
could represent the cellular heterogeneity found within the
mammosphere; with smaller cells being the stem cells [42] and
the larger cells being the progenitors and differentiated cells.
The label retention experiment (Fig. 1F) further highlighted the
existence of a functional hierarchy within mammospheres. Majority
of BrdU positive cells in T1 mammospheres may be predominantly
progenitors, while the few label retaining cells T4 spheres may
represent the true stem cells. Interestingly, someT4 spheres failed to
show any label-retaining cells. These spheres were also smaller in
size (30–40 mm), further supporting that the smaller spheres may
originate from progenitors. By the fifth passage, the vast majority of
the progenitor pool would have differentiated (see model Fig. 6),
withseveralofthemnot even survivingthe suspensionculture which
favors the growth of stem/progenitor cells, thereby accounting for
the massive cell loss observed in later passages (Fig. 3B).
CD24
low/CD44
high, and not SP cells, initiate mammospheres
The specific combination of CD24
low and CD44
high was found
to mark breast cancer stem cells [3]. Consistent with this result,
our data revealed that in the context of normal breast tissue too,
mammosphere forming potential resided only with those exhib-
iting the CD24
lowCD44
high phenotype. Interestingly, only the
CD24
lowCD44
high sub-fraction from primary mammospheres
generated cells of all the other phenotypes (Supp Fig. S3B),
thereby indicating that primary mammospheres indeed contain
stem cells that can undergo asymmetric division to self-renew and
generate the rest of the cells of the mammospheres. Our results
however revealed that the mammosphere SP fell within the non-
sphere initiating CD24
lowCD44
low profile. Even though SP from
human breast tissue or mammospheres have so far not been
transplanted into humanized, cleared fat pad for evaluation of
outgrowths [43], a previous study with murine mammary gland
reported that both SP and non-SP population could give
mammary outgrowths in vivo [34] thereby indicating that
mammary gland stem cells may well be outside the SP regime.
Similarly, in murine HSCs, only 10% of the Sca1 (a marker of
HSC) positive cells fall in the SP region [31]. Study of SP in
murine and human skin also revealed that these cells lacked stem
cell characteristics [44]. Similarly, in the neural tissue too, SP cells
from embryonic and adult forebrains did not generate NSC-
derived colonies, whereas the bulk population did [45]. ‘SP’
Figure 5. Senescence studies in mammospheres. A: Photomicrographs represent mammosphere-derived cells staining positive (blue color) for
senescence associated b Galactosidase (SA b Gal) activity at different passages; 620 objective. Trypsinized mammospheres were fixed with
glutaraldehyde and incubated in X-Gal containing buffer (pH 6.0). B: Graph represents quantitative representation of the senescence profile of
mammosphere-derived cells across passages, calculated by dividing the number of b Gal positive cells, as observed under the microscope, by the
total number of cells and represented as percentage. (n=6). Statistical analysis for B was done using One Way ANOVA. Error bars represent standard
deviation.
doi:10.1371/journal.pone.0005329.g005
Long Term Mammosphere Culture
PLoS ONE | www.plosone.org 9 April 2009 | Volume 4 | Issue 4 | e5329fundamentally reflects the status of membrane transporters and
thus, may or may not have a strong correlation with long term self
renewal potential – the hallmark of stem cells.
Lack of mammosphere formation beyond the fifth
passage
Our results demonstrated a total lack of sphere formation after
the fifth passage despite the presence of live (Fig. 3A and B),
proliferating (Fig. 4A), and label retaining cells (Fig. 1Fd). We
noticed an increased trend towards the myoepithelial lineage with
increasing passage, suggesting that manipulation of pathways that
regulate the decision between self-renewal and differentiation may
help in prolonging mammosphere life-span in culture. Indeed,
activation of the Notch and Hedgehog signaling pathway has been
shown to increase self-renewal of mammospheres [22,23].
However, whether they extend mammosphere life-span in culture
remains to be determined.
Characterization of the senescence profile of mammospheres at
every passage revealed a steady increase in the number of
senescent cells from T1 to T4 (Fig. 5A and B). Even though we
detected telomerase activity in T1 mammospheres, we failed to
both detect hTERT expression (Supp. Fig. S1D) and its activity
(Supp. Fig. S1C) in T4 spheres. Owing to the expression of
telomerase by adult stem cells, and their ability to grow in
anchorage independent conditions – two fundamental properties
of cancer cells – it is envisaged that adult stem cells may require
fewer genetic alterations to become carcinogenic. Yet, we
consistently failed to detect the emergence of any immortalized
or transformed cells in our mammosphere cultures spanning over
20 independent breast tissues, indicating that these cells have
stringent regulation of cell cycle and DNA damage response.
Senescence is also triggered by non-telomeric signals such as,
DNA damage, stress induced, culture conditions, or oncogenic
stress [46]. One of the major contributory factors for senescence in
the mammospheres culture system could be the culture condition,
in particular, oxygen concentration. While the ambient oxygen
tension is 20%, the in vivo concentration is between 1–3% in most
tissues [47]. The oxygen level is known to be even lower in the
stem cell niche in vivo [48,49]. Reactive oxygen species (ROS)
generated by such increased levels of oxygen is known to trigger
senescence [46]. To the contrary, culture of cells under low oxygen
tension has been shown to prevent or delay their premature
senescence [50–52]. Thus growing mammospheres in a hypoxic
environment may extend its life-span.
So, in the mammosphere culture system, the absence of
telomerase in late passage spheres, and continuous exposure to
high levels of oxygen, may result in widespread senescence. One
possibility is that the stem/progenitor pool itself undergoes
senescence. Another possibility is that the presence of a large
number of senescent cells around the non-senescent stem/
progenitor pool creates an unfavorable ‘niche’ for these primitive
cells, thereby altering their self renewal and differentiation
potential. The importance of the stem cell niche in regulating
stem cell behavior is well recognized [48], [53]. While the cell-cell
interactions, cell-extracellular matrix contacts, and response to
growth factors may provide a unique niche to the mammary stem
cells at early passages, the cues from accumulating senescent cells
at later passages may not mimic the same, thereby inhibiting the
stem cells from exhibiting their maximum self renewal potential
and preventing new sphere formation. This is also in keeping with
the growing notion that ‘stemness’ is a state of a cell as a
consequence of and maintained by the environment around the
cell [54], such that if this environment or ‘niche’ changes, the
stemness state of the cell is lost. Thus, in the mammosphere system
the label retaining cells within the mammosphere might represent
putative stem cells that have lost their stemness in the environment
of senescing cells. Thus, either modifications in culture conditions
to prevent senescence, or alterations in pathways regulating the
decision between self-renewal and differentiation could be
exploited to extend mammosphere life-span in culture.
Figure 6. A hypothetical model depicting cellular dynamics within mammospheres at various passages. Based on our observations
from serial sphere formation and label retention assays, differentiation and senescence analysis at each passage, we hypothesize that to begin with
there is a small number of stem cells, many rapidly dividing progenitors along with a few differentiated cells within each mammosphere. With time,
the progenitors differentiate, and the differentiated cells in turn either die or senesce. Some of the progenitors themselves might also senesce. The
increasing senescent environment might negatively influence the sphere forming potential of the actual stem cells that may still be present in the
senescent milieu at the end of a month, as shown by the label retaining cells.
doi:10.1371/journal.pone.0005329.g006
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Figure S1 Immunostaining and telomerase assay in mammo-
spheres. A and B: Immunostaining of intact T1 mammospheres
for CK 14 and 18 followed by optical sectioning of the stained
spheres using confocal microscopy. C: TRAP assay done for the
detection of functional telomerase in T2 and T4 mammospheres.
When viewed on a 12% polyacrylamide gel, while one could
observe a typical ladder pattern, which is representative of
functionally active telomerase in T2 spheres (Lane 2), no such
pattern was seen in T4 spheres (Lane 3). HEK 293T cells were
used as positive control (Lane 1) and lysis buffer as negative control
(Lane 4). SYBR green was used for detection. D: Detection of
telomerase expression from T1 to T4 mammospheres by Real
Time PCR. (HeLa cells were used as a positive control; human
fibroblasts (hF) and lysis buffer as negative controls).
Found at: doi:10.1371/journal.pone.0005329.s001 (1.16 MB
DOC)
Figure S2 Single cell sorting of CD24-/lowCD44high cells and
SP analysis of mouse bone marrow. Hoechst staining reveals a
distinct side population in C56BL/6 mouse bone marrow cells
used as positive control for SP staining of mammosphere derived
cells. A: Staining of mouse bone marrow cells with Hoechst 33342
shows presence of SP in region R2. B: The disappearance of the
side population (R2) in the presence of the transporter blocker
Verapamil. C: Single CD24-/lowCD44high sorted single cell
derived spheres formed in a 96-well ultra low attachment plate (a,
b); Cells derived from the single mammospheres stained for the
differentiation markers, CK 14 ( c ) and CK 18 (d).
Found at: doi:10.1371/journal.pone.0005329.s002 (1.80 MB
DOC)
Figure S3 Analysis of CD24 and CD44 expression. A:
Quantitative analysis of expression of the surface markers CD24
and CD44 in three tissues. B: Analysis of expression of CD24 and
CD44 by cells sorted from each depicted gates (refer to Fig. 2Cb)
after a week in culture in DMEM-F12 containing growth factors
seeded in a 24-well Ultra low attachment plate, stained with anti
CD24-FITC and anti CD44-PE antibodies. In each profile, the
region from which the cells had initially been sorted out has been
indicated in the respective region (1–4).
Found at: doi:10.1371/journal.pone.0005329.s003 (1.32 MB
DOC)
Figure S4 Differentiation potential of mammosphere derived
cells. A: Matrigel based 3D differentiation assay, results in
formation of spherical (a) and tubular (d) structures within the
gel after 15 days in culture. Optical section through the centre of
one of the matrigel derived spheres, revealing majority of acinar
structures (b and c). These structures stain positive for the
differentiation markers, CK 14 (myoepithelial cells) and CK 18
(luminal epithelial cells) (e–f) (blue: Hoechst; green: FITC; scale
bar for a and d is 25 mm; for b, c, e and f scale bar is 20 mm). B:
Differentiation assay carried out in serum reveals CK 14 positive
cells (a), CK 18 positive cells (b) and dual positive cells (c) Arrow
indicates cells which are positive for CK 14 but not CK 18 (red:
TRITC, green: FITC. Blue: Hoechst; scale bar represents 25 mm)
Found at: doi:10.1371/journal.pone.0005329.s004 (2.91 MB TIF)
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